MilliporeSigma builds biologics testing lab in Singapore

MilliporeSigma (MS) known in Europe as Merck, is opening a US$20 million, 3,800m² biologics testing laboratory in Singapore – the first of its kind outside the US and UK and the first in Singapore. Biologics testing is a major step in the drug development process to ensure sterility, safety and overall quality of customers’ biological drug products.

“This investment underscores our commitment to Singapore as an important hub for our company,” said Udit Batra, CEO. “Our new BioReliance lab in Singapore is the first of its kind for biomanufacturing in this region. And our reimagined ‘M Lab Collaboration Centre’, which recreates an actual manufacturing environment, emerged as part of our close work with the Singapore Economic Development Board.”

The Collaboration Centre will offer non-GMP lab space for training, hands-on demonstrations and process optimisation, supported by MS’s technical experts.